![]() |
市场调查报告书
商品编码
1800305
采血管市场:未来预测(2025-2030)Blood Collection Tubes Market - Forecasts fom 2025 to 2030 |
预计采血管市场规模将从 2025 年的 35.03 亿美元成长至 2030 年的 46.33 亿美元,复合年增长率为 5.75%。
由于慢性病盛行率上升、人口老化以及外科手术增多,全球采血管市场可望显着成长。血液检测和储存需求日益增长,尤其是对于糖尿病和癌症等需要频繁诊断的疾病,推动了该市场的蓬勃发展。采血管设计技术的进步,包括效率的提高和易用性的提升,进一步推动了需求的成长。儘管面临製造成本高昂和法规复杂等挑战,但强大的医疗基础设施仍为该市场提供了支撑,其中美国凭藉其先进的医疗生态系统和高检测量,正在成为市场主导。
市场驱动因素
糖尿病和癌症等慢性疾病的日益流行,是频繁进行血液检测以进行诊断和监测的主要驱动因素。世界卫生组织 (WHO) 报告称,全球共有 1,020 万例结核病病例,其中包括 120 万名儿童,这凸显了对可靠采血系统的需求。外科手术数量的增加也推动了市场成长,使得采血管对于术前和术后检测至关重要。例如,葡萄牙、丹麦、挪威和爱尔兰等欧洲国家的外科手术量很高,凸显了对高效采血解决方案的需求。此外,血清分离技术的进步,例如 BD 于 2023 年 1 月推出的含 K2EDTA 的 Vacutainer® 血清管,提高了可用性并支持外科手术,进一步推动了市场扩张。 WHO 2023 年 6 月的资料显示,共采集了 1.185 亿个采血管。全球捐血的增加进一步扩大了对专用采血管的需求,以确保血液的安全储存和检测。
The Blood Collection Tubes Market is expected to grow from USD 3.503 billion in 2025 to USD 4.633 billion in 2030, at a CAGR of 5.75%.
The global blood collection tubes market is poised for significant growth, driven by the rising prevalence of chronic diseases, an aging population, and increasing surgical procedures. The market is fueled by the growing need for blood testing and storage, particularly for conditions like diabetes and cancer, which require frequent diagnostics. Technological advancements in tube design, such as improved efficiency and user-friendliness, further propel demand. Despite challenges like high production costs and regulatory complexities, the market is supported by robust healthcare infrastructure, with the United States emerging as a dominant market due to its advanced medical ecosystem and high testing volumes.
Market Drivers
The increasing incidence of chronic diseases, such as diabetes and cancer, is a primary driver, necessitating frequent blood tests for diagnosis and monitoring. The World Health Organization reported 10.2 million tuberculosis cases globally, including 1.2 million children, highlighting the demand for reliable blood collection systems. The growing number of surgical procedures also boosts market growth, as blood collection tubes are essential for preoperative and postoperative testing. For instance, high surgical volumes in European countries like Portugal, Denmark, Norway, and Ireland underscore the need for efficient blood collection solutions. Additionally, technological advancements, such as BD's Vacutainer(R) Serum Tube with K2EDTA launched in January 2023 for serum separation, enhance usability and support surgical applications, driving market expansion. The global rise in blood donations, with 118.5 million units collected as per WHO's June 2023 data, further amplifies demand for specialized tubes to ensure safe storage and testing.
Market Segmentation
The market is segmented by application, tube type, and geography. Applications include diagnostics, surgical procedures, and blood donation, with diagnostics leading due to chronic disease prevalence. Tube types encompass serum, plasma, and EDTA tubes, tailored to specific testing needs. Geographically, the market spans North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The United States dominates North America, driven by its USD 3.8 trillion healthcare industry in 2022 and high surgical and diagnostic activity. The integration of microfluidics in point-of-care (POC) diagnostics, enabling portable and affordable testing, further supports market growth in the region.
Industry Analysis
Porter's Five Forces model evaluates competitive dynamics, analyzing supplier power, buyer influence, and market rivalry. An industry value chain analysis identifies key players in tube manufacturing, distribution, and healthcare integration, emphasizing their roles in ensuring quality and efficiency. The regulatory framework, including standards for medical device safety and quality, is critical for maintaining trust and compliance, particularly in high-income countries with stringent healthcare regulations.
Competitive Landscape
Key players, such as BD, focus on innovation, developing advanced tubes like the Vacutainer(R) series to meet surgical and diagnostic needs. The vendor matrix categorizes companies as leaders, followers, challengers, or niche players based on their strategies, with an emphasis on user-friendly and efficient solutions. Investments in R&D and partnerships with healthcare providers strengthen market positions.
Challenges
High production costs for advanced blood collection tubes and stringent regulatory requirements pose barriers. Ensuring consistent quality across diverse applications and addressing supply chain constraints in developing regions are additional challenges requiring strategic solutions.
The blood collection tubes market is set for robust growth, driven by chronic disease prevalence, surgical demand, and technological advancements. The U.S. leads due to its advanced healthcare infrastructure and high testing volumes, while Asia Pacific shows potential with rising healthcare needs. Continued innovation and regulatory compliance will be critical for overcoming cost and quality challenges, ensuring the market meets global diagnostic and surgical demands.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Segmentation: